Triple therapy for CLL: pembrolizumab, ublituximab and umbralisib
Challenges in CLL - Richter's transformation and acute leukemia
Do patients with CLL require CAR T-cell therapy?
Novel therapies in the future of CLL treatment
Preliminary results of ibruntinib in combination with FCR chemotherapy for CLL